Literature DB >> 10490091

Identification of a 6 base pair insertion in West Highland White Terriers with erythrocyte pyruvate kinase deficiency.

B J Skelly1, M Wallace, Y R Rajpurohit, P Wang, U Giger.   

Abstract

OBJECTIVE: To define the disease-causing mutation in West Highland White Terriers (WHWT) with erythrocyte pyruvate kinase (R-PK) deficiency and to design a genetic test capable of recognizing affected (homozygous) and carrier (heterozygous) dogs. ANIMALS: 3 anemic WHWT littermates and 1 unaffected littermate; 16 dogs from the same kennel, including 4 unrelated, phenotypically normal dogs (control dogs), and 12 for which PK activity was not known; 2 PK-deficient Basenjis; 2 PK-deficient Beagles; 4 unaffected English Springer Spaniels; and 1 mixed-breed dog. PROCEDURES: cDNA was cloned and sequenced, and cDNA sequences were compared with the published sequence for canine R-PK cDNA to identify the putative disease-causing mutation. Genomic DNA spanning the affected region was cloned and sequenced to verify the mutation. Subsequently, polymerase chain reaction primers were designed to amplify the section of the gene containing the mutation from DNA in blood or buccal swab samples. Gel electrophoresis allowed assignment of genotypes on the basis of allele separation.
RESULTS: 4 single base polymorphisms attributable to sequencing errors in the published sequence were identified, along with a 6 base pair (bp) insertion in exon 10 that was recognized as a putative disease-causing mutation. An identical insertion was found in genomic DNA. Amplification of genomic DNA yielded a 117 bp product for genotypically normal dogs and a 123 bp product for WHWT homozygous for PK deficiency. Carriers had 1 copy of each allele and variable heteroduplex structures. CONCLUSIONS AND CLINICAL RELEVANCE: A 6 bp insertion in the C domain of R-PK was identified in WHWT with PK deficiency. Affected and carrier dogs could be distinguished with a genetic test.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490091

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  7 in total

1.  Web resource on available DNA variant tests for hereditary diseases and genetic predispositions in dogs and cats: An Update.

Authors:  Jennifer L Rokhsar; Julia Canino; Karthik Raj; Scott Yuhnke; Jeffrey Slutsky; Urs Giger
Journal:  Hum Genet       Date:  2021-02-06       Impact factor: 4.132

2.  Missense mutation in PFKM associated with muscle-type phosphofructokinase deficiency in the Wachtelhund dog.

Authors:  G Inal Gultekin; K Raj; S Lehman; A Hillström; U Giger
Journal:  Mol Cell Probes       Date:  2012-03-16       Impact factor: 2.365

3.  Erythrocytic pyruvate kinase mutations causing hemolytic anemia, osteosclerosis, and seconday hemochromatosis in dogs.

Authors:  G Inal Gultekin; K Raj; P Foureman; S Lehman; K Manhart; O Abdulmalik; U Giger
Journal:  J Vet Intern Med       Date:  2012 Jul-Aug       Impact factor: 3.333

4.  Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems.

Authors:  Thomas R Bauer; Rima L Adler; Dennis D Hickstein
Journal:  ILAR J       Date:  2009

5.  Real-time PCR genotyping assay for feline erythrocyte pyruvate kinase deficiency and mutant allele frequency in purebred cats in Japan.

Authors:  Kazuya Kushida; Urs Giger; Toshihiko Tsutsui; Megumi Inaba; Yoshio Konno; Kureha Hayashi; Kana Noguchi; Akira Yabuki; Keijiro Mizukami; Moeko Kohyama; Yasuyuki Endo; Osamu Yamato
Journal:  J Vet Med Sci       Date:  2015-02-13       Impact factor: 1.267

6.  Erythrocyte pyruvate kinase deficiency mutation identified in multiple breeds of domestic cats.

Authors:  Robert A Grahn; Jennifer C Grahn; Maria Ct Penedo; Chris R Helps; Leslie A Lyons
Journal:  BMC Vet Res       Date:  2012-10-30       Impact factor: 2.741

7.  Erythrocyte pyruvate kinase deficiency in three West Highland white terriers in Ireland and the UK.

Authors:  Florence Juvet; Urs Giger; Ian Battersby; Pierre Menaut; Harriet M Syme; Carmel T Mooney
Journal:  Ir Vet J       Date:  2013-07-10       Impact factor: 2.146

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.